bupropion hydrochloride sr

Generic: bupropion hydrochloride

Labeler: northwind health company, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride sr
Generic Name bupropion hydrochloride
Labeler northwind health company, llc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
Northwind Health Company, LLC

Identifiers & Regulatory

Product NDC 51655-115
Product ID 51655-115_48c3c65d-777b-3c63-e063-6394a90a1176
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211347
Listing Expiration 2027-12-31
Marketing Start 2022-10-05

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51655115
Hyphenated Format 51655-115

Supplemental Identifiers

RxCUI
993518
UNII
ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride sr (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA211347 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-25)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-26)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-52)
  • 180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-83)
source: ndc

Packages (4)

51655-115-25 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-25) 51655-115-26 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-26) 51655-115-52 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-52) 51655-115-83 180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-83)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

Bupropion Hydrochloride SR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "48c3c65d-777b-3c63-e063-6394a90a1176", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["f2b3939b-a410-6354-e053-2995a90ababb"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-25)", "package_ndc": "51655-115-25", "marketing_start_date": "20221005"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-26)", "package_ndc": "51655-115-26", "marketing_start_date": "20221115"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-52)", "package_ndc": "51655-115-52", "marketing_start_date": "20221130"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-83)", "package_ndc": "51655-115-83", "marketing_start_date": "20230105"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "51655-115_48c3c65d-777b-3c63-e063-6394a90a1176", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "51655-115", "generic_name": "bupropion hydrochloride", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA211347", "marketing_category": "ANDA", "marketing_start_date": "20221005", "listing_expiration_date": "20271231"}